Cellex Overview

  • Founded

  • 2002

Founded
  • Status

  • Private

  • Employees

  • 3

Employees
  • Latest Deal Type

  • Grant

  • Latest Deal Amount

  • $2.48M

  • Investors

  • 5

Cellex General Information

Description

Dveloper of medical diagnostic tests designed for testing human diseases and conditions. The company's platform offers two versions of a real-time Neuraminidase Inhibitor assay, which is designed for influenza diagnosis and drug resistance detection, enabling healthcare to do a rapid detection that can help save lives.

Contact Information

Website
cellex.us
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • 507 Airport Boulevard
  • Suite 107
  • Morrisville, NC 27560
  • United States
+1 (800) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 01-Mar-2011 $2.48M 00000 Completed Generating Revenue
5. Accelerator/Incubator 12-Aug-2010 00000 00000 Completed Generating Revenue
4. Grant 01-Jan-2010 000 00000 Completed Generating Revenue
3. Accelerator/Incubator 06-Feb-2009 00000 00000 Completed Generating Revenue
2. Grant 15-Aug-2008 $1.91M Completed Generating Revenue
1. Grant 01-May-2005 $2.44M Completed Startup
To view Cellex’s complete valuation and funding history, request access »

Cellex Patents

  • 14

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Cellex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D939105-S1 Testing cassette Active 02-Sep-2020
US-20210356464-A1 Serological assays for diagnosing or confirming covid-19 virus infections Pending 05-May-2020 000000000000
US-20210301319-A1 Protease assays and their applications Pending 26-Mar-2020 00000000
AU-2015247955-A1 Methods and devices for detection of resistance to an enzyme inhibitor Inactive 15-Apr-2014 00000000
CA-2977634-A1 Methods and devices for detection of resistance to an enzyme inhibitor Inactive 15-Apr-2014 C12Q1/34
To view Cellex’s complete patent history, request access »

Cellex Executive Team (1)

Name Title Board Seat Contact Info
James Li Ph.D Chief Executive Officer & Founder
To view Cellex’s complete executive team members history, request access »

Cellex Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellex Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Maryland Industrial Partnerships University Minority 000 0000 000000 0
United States Department of Agriculture Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
Small Business Innovation Research and Small Business Technology Transfer Programs Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Cellex’s complete investors history, request access »

Ready to get started?

Request a free trial